-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
March 15, 2007 - nonpolyposis colon cancer syndromes (Lynch I or II) were excluded because these syndromes account for a small percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
March 01, 2007 - nonpolyposis colon cancer syndromes (Lynch I or II)
were excluded because these syndromes account for a small
percentage
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
April 25, 2017 - The percentage of cases correctly classified based on a predefined false-positive risk threshold. 27
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
March 01, 2016 - the highest-quality and largest trial (n = 3346), 15 universal vision screening identified a greater percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
November 01, 2011 - However, specificity for
CIN2� and CIN3� was consistently 3 to 5 percentage
points lower for HPV testing
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
July 30, 2013 - Approximately 85% of lung cancer cases in the United States are attributable to smoking 7 , 8 , and a high percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zYdjLaTCTBVUwgJTnzpVXr
May 08, 2018 - , including that it only examined 1-time PSA-based screen-
ing and the small difference between the percentage
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
August 22, 2023 - discontinuation: 0.07% (2/2694) vs 0.2% (6/2693); RR, 0.33 (95% CI, 0.07-1.65) Creatinine clearance, median percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9Hht_QpMB4gQg26rTpcaN
November 01, 2013 - , and unclear spec-
trum of patients due to poor reporting of how study pop-
ulation was derived or percentage … From trial data, the percentage of persons stop-
ping memantine therapy due to adverse effects was similar
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Latent Tuberculosis Infection in Adults: Screening
May 02, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They should no…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-2005
July 12, 2005 - Measurement of percentage of body fat in 411 children and adolescents: a comparison of dual-energy X-ray
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cervical-cancer-screening
August 21, 2018 - g Percentage of women; converted from rate per 1000 participants.
h From author inquiry.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
March 01, 2016 - the highest-quality and
largest trial (n = 3346),15 universal vision screening identified a
greater percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
March 09, 2021 - evaluation of false-positive
results.22,30,31,34,43,62-64,66,72,75,79,81,85 Among all patients screened,
the percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
September 09, 2021 - treatment (ie, a prespeci-
fied level of symptom reduction, such as a certain number of
points or a percentage
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
March 15, 2007 - Placebo
Sulindac, 150 mg orally BID for 4 mo
( n = 22)
Primary end point: percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
March 01, 2007 - cardiac
disease; polyps �1 cm
Placebo Sulindac, 150 mg
orally BID for 4
mo (n � 22)
Primary end point:
percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/8LBrrLzvtemZYcdNSjToKz
December 01, 2014 - improvements in some behavioral
outcomes at some time point;
pooled analysis showed a 29%
increase in percentage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6desD2XJCQKF8ZDPMS-NU_
July 01, 2005 - Measurement of
percentage of body fat in 411 children
and adolescents: a comparison of dual-
energy
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
January 01, 2020 - Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Screening for Breast Cancer: U.S. Preventive Services Task Force
Recommendation Statement
Albert L. Siu, MD, MSPH, on behalf of the U.S. Preventive Services Task Force
Description: Update of the 2009 U.S. Preventive Services Ta…